Contact Person : Ghyslaine Lebougault; Last Date for the submission of abstract : 15/07/2011; Description : Biology of CML including the origin of BCR-ABL1, signal transduction, basis of disease progression, action of tyrosine kinase inhibitors and mechanisms underlying resistance to TKI, and Aspects of treatment.